Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Bulletin Du Cancer|January 1, 1987
[Serum and cerebrospinal fluid levels after high dose of etoposide administrated intravenously]J P Kleisbauer, N Lena-Nosny, D VescoBiochemical Pharmacology|December 1, 1986
Kinetics of uptake and intracellular binding of Cyclosporine A in RAJI cells, in vitroI Fabre, G Fabre, N Lena, et al.European Journal of Cancer & Clinical Oncology|September 1, 1987
Methotrexate and 7-hydroxy-methotrexate pharmacokinetics following intravenous bolus administration and high-dose infusion of methotrexateP Bore, R Bruno, N Lena, et al.European Journal of Cancer & Clinical Oncology|May 1, 1987
Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexateN Lena, A M Imbert, R Favre, et al.Cancer Drug Delivery|January 1, 1987
Kinetics of methotrexate and its metabolites in red blood cellsN Lena, A M Imbert, P Brunet, et al.Cancer Drug Delivery|January 1, 1985
Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocolJ P Cano, R Bruno, N Lena, et al.Cancer Drug Delivery|January 1, 1985
Dosage predictions in high-dose methotrexate infusions. Part 2: Bayesian estimation of methotrexate clearanceR Bruno, A Iliadis, R Favre, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behaviorN Lena, A M Imbert, T Pignon, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesineP Bore, N Lena, A M Imbert, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Methotrexate-vindesine association in leukemia: pharmacokinetic studyN Tubiana, N Lena, J Barbet, et al.Pageof 2